Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients
Translational Lung Cancer Research · 2024-10 · 13 (10) · 2549-2560
DOI: 10.21037/tlcr-24-336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Lung Cancer Research, 2024-10. Verfasst von Quan Zheng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China. Die Arbeit wurde bisher 9-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
The appreciation of sex differences is substantial for precise cancer management. Surgery is the main treatment for non-small cell lung cancer (NSCLC). We aimed to identify sex differences on perioperative outcomes in NSCLC patients and to uncover the origins of sex effect in outcomes using a Chinese cohort.
Methods
We retrospectively enrolled patients undergoing NSCLC surgery in the Western China Lung Cancer Database from January 2014 to April 2021. We compared baseline characteristics and perioperative outcomes between male and female. Multivariable analyses were performed. We conducted causal mediation analysis to identify drivers to sex differences in perioperative outcomes.
Results
Altogether, data of 10,181 patients (5,738 women and 4,443 men) were analyzed. Women had lower incidence of complications (5.05% vs. 12.15%), shorter postoperative length of stays (4.92 vs. 6.41 days), and less hospitalization cost (50,713.69 vs. 54,580.85, Chinese Yuan). Multivariable regression analysis identified sex as an independent factor of perioperative complications [odds ratio (OR), 1.843, 95% confidence interval (CI): 1.476-2.294], as well as of postoperative length of hospital stays (beta 0.123, 95% CI: 0.099-0.148), and hospitalization cost (beta 0.026, 95% CI: 0.026-0.026). Mediation analysis revealed that age, body mass index, prevalence of chronic obstructive pulmonary disease, predicted diffusion capacity for carbon monoxide, tumor size, pleural adhesion, and surgery duration were identified as mediators for sex differences in outcomes, while smoking status, surgery type, and resection extent were not.
Conclusions
Female NSCLC patients demonstrated lower incidence of complications, shorter postoperative length of stays, and less hospitalization cost after surgery. Those differences between men and women could be explained by their inherent biological differences and baseline health status. Perioperative management strategies for NSCLC should prioritize recognizing the potentially poorer outcomes among male patients and implementing tailored precautions accordingly.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic Surgery and Institute of Thoracic Oncology, West China Hospital, Sichuan University, Chengdu, China.
- Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
- West China School of Medicine, Sichuan University, Chengdu, China.
ORCID-Profile: Lunxu Liu
Zitieren
APA
Zheng, Q., Zhou, J., Zhang, Y., Wang, T., Wu, D., Pu, Q., Mei, J., Liao, H., & Liu, L. (2024). Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients. Translational Lung Cancer Research, 13(10), 2549-2560. https://doi.org/10.21037/tlcr-24-336
Vancouver
Zheng Q, Zhou J, Zhang Y, Wang T, Wu D, Pu Q, et al. Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients. Translational Lung Cancer Research. 2024;13(10):2549-2560. doi:10.21037/tlcr-24-336
BibTeX
@article{Zheng2024,
author = {Zheng, Quan and Zhou, Jian and Zhang, Yuanjin and Wang, Tengyong and Wu, Dongsheng and Pu, Qiang and Mei, Jiandong and Liao, Hu and Liu, Lunxu},
title = {Insights into sex differences in perioperative outcomes of non-small cell lung cancer patients},
journal = {Translational Lung Cancer Research},
year = {2024},
volume = {13},
number = {10},
pages = {2549--2560},
doi = {10.21037/tlcr-24-336}
}
EUVIMED